Literature DB >> 11844741

Oscillatory mechanism in primary sensory neurones.

Ron Amir1, Chang-Ning Liu, Jeffery D Kocsis, Marshall Devor.   

Abstract

Ectopic spike activity, generated at low levels in intact sensory dorsal root ganglia and intensified following axotomy, is an important cause of neuropathic pain. The spikes are triggered by subthreshold membrane potential oscillations. The depolarizing phase of oscillation sinusoids is due to a phasic voltage-sensitive Na(+) conductance (gNa(+)). Here we examine the repolarizing phase for which K(+) conductance (gK(+)) is implicated. In vivo, gK(+) blockers have excitatory effects inconsistent with the elimination of oscillations. Indeed, using excised dorsal root ganglia in vitro, we found that gK(+) block does not eliminate oscillations; on the contrary, it has a variety of facilitatory effects. However, oscillations were eliminated by shifting the K(+) reversal potential so as to neutralize voltage-insensitive K(+) leak channels. Based on these data, we propose a novel oscillatory model: oscillation sinusoids are due to reciprocation between a phasically activating voltage-dependent, tetrodotoxin-sensitive Na(+) conductance and passive, voltage-independent K(+) leak. In drug-free media, voltage-sensitive K(+) channels act to suppress oscillations and increase their frequency. Numerical simulations support this model and account for the effects of gK(+) block. Oscillations in dorsal root ganglia neurones appear to be based on the simplest possible configuration of ionic conductances compatible with sustained high frequency oscillatory behaviour. The oscillatory mechanism might be exploited in the search for novel analgesic drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844741     DOI: 10.1093/brain/awf037

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  31 in total

1.  Subthreshold oscillations induced by spinal nerve injury in dissociated muscle and cutaneous afferents of mouse DRG.

Authors:  Chang-Ning Liu; Marshall Devor; Stephen G Waxman; Jeffery D Kocsis
Journal:  J Neurophysiol       Date:  2002-04       Impact factor: 2.714

2.  Membrane properties of an unusual intrinsically oscillating, wide-field teleost retinal amacrine cell.

Authors:  Eduardo Solessio; Jozsef Vigh; Nicolas Cuenca; Kevin Rapp; Eric M Lasater
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

3.  Imbalance of ionic conductances contributes to diverse symptoms of demyelination.

Authors:  Jay S Coggan; Steven A Prescott; Thomas M Bartol; Terrence J Sejnowski
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 4.  Strategies for finding new pharmacological targets for neuropathic pain.

Authors:  Marshal Devor
Journal:  Curr Pain Headache Rep       Date:  2004-06

5.  Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons.

Authors:  Ron Amir; Jeffery D Kocsis; Marshall Devor
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

6.  Time-dependent molecular memory in single voltage-gated sodium channel.

Authors:  Tapan K Nayak; S K Sikdar
Journal:  J Membr Biol       Date:  2007-09-01       Impact factor: 1.843

Review 7.  Ectopic discharge in Abeta afferents as a source of neuropathic pain.

Authors:  Marshall Devor
Journal:  Exp Brain Res       Date:  2009-02-26       Impact factor: 1.972

8.  Schwann cell engraftment into injured peripheral nerve prevents changes in action potential properties.

Authors:  Kewei Yu; Jeffery D Kocsis
Journal:  J Neurophysiol       Date:  2005-08       Impact factor: 2.714

9.  The modulation of voltage-gated potassium channels by anisotonicity in trigeminal ganglion neurons.

Authors:  L Chen; C Liu; L Liu
Journal:  Neuroscience       Date:  2008-03-29       Impact factor: 3.590

10.  Ranolazine attenuates behavioral signs of neuropathic pain.

Authors:  Harry J Gould; Colleen Garrett; Renee R Donahue; Dennis Paul; Ivan Diamond; Bradley K Taylor
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.